Intuitive Surgical (ISRG) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $427.86, +1.81% vs the prior close of $420.24.
- Volume 2.06M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ISRG rises 1.8% to $427.86, a 3-month high. Closed at $427.86, +1.81% vs the prior close of $420.24. Day range $419.54–$429.89, opened at $425.50.
ISRG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ISRG rises 1.8% to $427.86, a 3-month high
- Closed at $427.86, +1.81% vs the prior close of $420.24. Day range $419.54–$429.89, opened at $425.50.
- Volume was 2.06M shares, 0.9x its 50-day average of 2.30M.
- Price is +9.5% vs its 50-day average ($390.61) and -2.8% vs its 200-day average ($440.36).
- 52-week range $328.57–$603.88; today's close sits at 36% of that range, 29.1% below the 52-week high.
Oct 14, 2026 — ISRG dips 0.4% to $420.24
- Closed at $420.24, -0.43% vs the prior close of $422.06. Day range $414.65–$425.50, opened at $424.81.
- Volume was 1.91M shares, 0.8x its 50-day average of 2.34M.
- Price is +7.9% vs its 50-day average ($389.56) and -4.7% vs its 200-day average ($441.10).
- 52-week range $328.57–$603.88; today's close sits at 33% of that range, 30.4% below the 52-week high.
Oct 13, 2026 — ISRG dips 1.3% to $422.06
- Closed at $422.06, -1.30% vs the prior close of $427.64. Day range $416.37–$430.00, opened at $430.00.
- Volume was 1.73M shares, 0.7x its 50-day average of 2.38M.
- Price is +8.6% vs its 50-day average ($388.52) and -4.5% vs its 200-day average ($441.89).
- 52-week range $328.57–$603.88; today's close sits at 34% of that range, 30.1% below the 52-week high.
Oct 12, 2026 — ISRG rises 0.9% to $427.64, a 3-month high, 4 up days in a row
- Closed at $427.64, +0.87% vs the prior close of $423.96. Day range $421.03–$429.27, opened at $423.00.
- Volume was 1.62M shares, 0.7x its 50-day average of 2.39M.
- Price is +10.3% vs its 50-day average ($387.58) and -3.4% vs its 200-day average ($442.66).
- 52-week range $328.57–$603.88; today's close sits at 36% of that range, 29.2% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — ISRG rises 2.1% to $423.96, a 3-month high, 3 up days in a row
- Closed at $423.96, +2.06% vs the prior close of $415.41. Day range $415.86–$427.53, opened at $416.39.
- Volume was 1.76M shares, 0.7x its 50-day average of 2.41M.
- Price is +9.8% vs its 50-day average ($386.10) and -4.4% vs its 200-day average ($443.41).
- 52-week range $328.57–$603.88; today's close sits at 35% of that range, 29.8% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — ISRG ends flat (+0.2%) to $415.41, a 3-month high
- Closed at $415.41, +0.21% vs the prior close of $414.52. Day range $407.70–$416.72, opened at $411.60.
- Volume was 2.53M shares, 1.0x its 50-day average of 2.42M.
- Price is +8.0% vs its 50-day average ($384.68) and -6.5% vs its 200-day average ($444.19).
- 52-week range $328.57–$603.88; today's close sits at 32% of that range, 31.2% below the 52-week high.
Oct 7, 2026 — ISRG rises 2.4% to $414.52
- Closed at $414.52, +2.41% vs the prior close of $404.76. Day range $404.20–$416.81, opened at $405.07.
- Volume was 1.90M shares, 0.8x its 50-day average of 2.46M.
- Price is +8.1% vs its 50-day average ($383.43) and -6.8% vs its 200-day average ($444.98).
- 52-week range $328.57–$603.88; today's close sits at 31% of that range, 31.4% below the 52-week high.
Oct 6, 2026 — ISRG dips 0.4% to $404.76
- Closed at $404.76, -0.42% vs the prior close of $406.48. Day range $402.00–$409.34, opened at $405.20.
- Volume was 1.65M shares, 0.7x its 50-day average of 2.53M.
- Price is +5.9% vs its 50-day average ($382.38) and -9.2% vs its 200-day average ($445.71).
- 52-week range $328.57–$603.88; today's close sits at 28% of that range, 33.0% below the 52-week high.
Oct 5, 2026 — ISRG jumps 3.7% to $406.48
- Closed at $406.48, +3.71% vs the prior close of $391.95. Day range $389.11–$407.63, opened at $389.76.
- Volume was 1.66M shares, 0.6x its 50-day average of 2.57M.
- Price is +6.6% vs its 50-day average ($381.42) and -9.0% vs its 200-day average ($446.48).
- 52-week range $328.57–$603.88; today's close sits at 28% of that range, 32.7% below the 52-week high.
Oct 2, 2026 — ISRG dips 2.3% to $391.95, 4 down days in a row
- Closed at $391.95, -2.32% vs the prior close of $401.24. Day range $391.39–$406.47, opened at $405.15.
- Volume was 1.83M shares, 0.7x its 50-day average of 2.63M.
- Price is +3.1% vs its 50-day average ($380.04) and -12.4% vs its 200-day average ($447.22).
- 52-week range $328.57–$603.88; today's close sits at 23% of that range, 35.1% below the 52-week high.
- That makes 4 straight losses.
ISRG latest news & SEC filings
Every SEC filing by or about ISRG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Widman Fredrik sold 543 shares at $374.44 (≈$203.32K) on Sep 15, 2026
- Widman Fredrik sold 546 shares at $374.44 (≈$204.44K) on Sep 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brosius Mark sold 25 shares at $365.79 (≈$9.14K) on Sep 11, 2026
- Brosius Mark sold 23 shares at $347.66 (≈$8.00K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brosius Mark sold 23 shares at $350.20 (≈$8.05K) on Sep 9, 2026
- Brosius Mark sold 46 shares at $361.23 (≈$16.62K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 27, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 21, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Jul 21, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.89B (prior year $2.44B) (+18.5% vs Jun 30, 2025)
- Net income: $818.10M (prior year $658.40M) (+24.3% vs Jun 30, 2025)
- Diluted EPS: $2.29 (prior year $1.81) (+26.5% vs Jun 30, 2025)
Jul 16, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade ISRG
- Last results release: Jul 16, 2026 (8-K Item 2.02). Previous ones: Apr 21, 2026, Jan 22, 2026, Jan 14, 2026. Based on that rhythm, the next report is likely around Oct 15, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.43% (largest 3.7%).
- Liquidity: about 2.09M shares (≈$894.13M) trade per day on average.
- 52-week position: $427.86 vs a range of $328.57–$603.88 (36% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Fredrik Widman sold 543 shares on Sep 15, 2026.
- Latest filings: 8-K Jul 27, 2026; 10-Q Jul 21, 2026; 8-K Jul 16, 2026.
- Share count: 353.28M shares outstanding (Jul 16, 2026), -1.5% vs a year earlier.
- Listing: Nasdaq · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
ISRG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 425.50 | 429.89 | 419.54 | 427.86 | 2.06M |
| Oct 14, 2026 | 424.81 | 425.50 | 414.65 | 420.24 | 1.91M |
| Oct 13, 2026 | 430.00 | 430.00 | 416.37 | 422.06 | 1.73M |
| Oct 12, 2026 | 423.00 | 429.27 | 421.03 | 427.64 | 1.62M |
| Oct 9, 2026 | 416.39 | 427.53 | 415.86 | 423.96 | 1.76M |
| Oct 8, 2026 | 411.60 | 416.72 | 407.70 | 415.41 | 2.53M |
| Oct 7, 2026 | 405.07 | 416.81 | 404.20 | 414.52 | 1.90M |
| Oct 6, 2026 | 405.20 | 409.34 | 402.00 | 404.76 | 1.65M |
| Oct 5, 2026 | 389.76 | 407.63 | 389.11 | 406.48 | 1.66M |
| Oct 2, 2026 | 405.15 | 406.47 | 391.39 | 391.95 | 1.83M |
| Oct 1, 2026 | 409.05 | 410.52 | 399.25 | 401.24 | 1.51M |
| Sep 30, 2026 | 408.05 | 410.74 | 405.51 | 406.63 | 1.66M |
| Sep 29, 2026 | 411.90 | 414.20 | 407.07 | 412.18 | 1.89M |
| Sep 28, 2026 | 405.18 | 416.51 | 402.75 | 414.79 | 2.57M |
| Sep 25, 2026 | 397.65 | 406.39 | 391.92 | 405.18 | 2.50M |
| Sep 24, 2026 | 396.73 | 404.19 | 395.18 | 399.52 | 1.56M |
| Sep 23, 2026 | 400.88 | 404.44 | 396.05 | 398.30 | 1.69M |
| Sep 22, 2026 | 403.00 | 403.97 | 397.72 | 402.09 | 1.86M |
| Sep 21, 2026 | 393.89 | 403.48 | 391.04 | 401.65 | 2.97M |
| Sep 18, 2026 | 381.51 | 394.91 | 379.50 | 393.33 | 4.93M |
About Intuitive Surgical
Intuitive Surgical (ISRG) is listed on the Nasdaq and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in SUNNYVALE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1035267.
ISRG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Craig H Barratt | Director | Apr 30, 2026 |
| Joseph C Beery | Director | Apr 30, 2026 |
| Lewis Chew | Director | Apr 30, 2026 |
| Gary S Guthart | Director | Aug 12, 2026 |
| Amal M Johnson | Director | Apr 30, 2026 |
| Sreelakshmi Kolli | Director | Apr 30, 2026 |
| Amy L Ladd | Director | Aug 11, 2026 |
| Keith R Leonard | Director | Apr 30, 2026 |
| Jami K Nachtsheim | Director | Apr 30, 2026 |
| Monica P Reed | Director | Apr 30, 2026 |
| David J. Rosa | Chief Executive Officer (CEO) | Jul 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark Brosius | EVP & Chief Mfg and Supply Cha | Sep 11, 2026 |
| Henry L Charlton | EVP & Chief Commercial and Mkt | Mar 2, 2026 |
| Myriam Curet | EVP & Chief Medical Officer | Mar 11, 2026 |
| Iman Jeddi | SVP & GM da Vinci Platforms & | Jun 2, 2026 |
| Gary Loeb | EVP & Chief Legal and Complian | Aug 10, 2026 |
| Brian Edward Miller | EVP & Chief Digital Officer | Nov 12, 2025 |
| David J. Rosa | Chief Executive Officer (CEO) | Jul 13, 2026 |
| Jamie Samath | EVP & CFO & Enterprise Technol | Mar 2, 2026 |
| Patricia L Wadors | SVP Chief Human Resources Offi | Feb 27, 2026 |
| Fredrik Widman | VP Corporate Controller | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Fredrik Widman | Sale | 543 | $374.44 |
| Sep 15, 2026 | Fredrik Widman | Sale | 546 | $374.44 |
| Sep 11, 2026 | Mark Brosius | Sale | 25 | $365.79 |
| Sep 10, 2026 | Mark Brosius | Sale | 23 | $347.66 |
| Sep 9, 2026 | Mark Brosius | Sale | 23 | $350.20 |
| Sep 8, 2026 | Mark Brosius | Sale | 46 | $361.23 |
| Aug 21, 2026 | Mark Brosius | Sale | 77 | $375.57 |
| Aug 20, 2026 | Mark Brosius | Sale | 77 | $396.37 |
| Aug 19, 2026 | Mark Brosius | Sale | 77 | $394.26 |
| Aug 18, 2026 | Mark Brosius | Sale | 77 | $394.00 |
| Aug 17, 2026 | Mark Brosius | Sale | 77 | $390.67 |
| Aug 11, 2026 | Gary S Guthart | Sale | 10,000 | $400.00 |
| Aug 11, 2026 | Amy L Ladd | Sale | 72 | $393.10 |
| Aug 10, 2026 | Amy L Ladd | Sale | 400 | $379.00 |
| Aug 10, 2026 | Gary Loeb | Sale | 400 | $379.00 |
ISRG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $10.06B | $2.86B | 7.87 | $3.03B |
| Dec 31, 2024 | $8.35B | $2.32B | 6.42 | $2.42B |
| Dec 31, 2023 | $7.12B | $1.80B | 5.03 | $1.81B |
| Dec 31, 2022 | $6.22B | $1.32B | 3.65 | $1.49B |
| Dec 31, 2021 | $5.71B | $1.70B | 4.66 | $2.09B |
Latest balance sheet: total assets $20.88B, total liabilities $2.58B, cash $2.76B (as of Jun 30, 2026).
ISRG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 16, 2026 | 8-K Item 2.02 (results) | $402.33 |
| Apr 21, 2026 | 8-K Item 2.02 (results) | $451.29 |
| Jan 22, 2026 | 8-K Item 2.02 (results) | $525.81 |
| Jan 14, 2026 | 8-K Item 2.02 (results) | $546.76 |
| Oct 21, 2025 | 8-K Item 2.02 (results) | $462.74 |
| Jul 22, 2025 | 8-K Item 2.02 (results) | $511.00 |
| Apr 22, 2025 | 8-K Item 2.02 (results) | $478.74 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $608.66 |
| Jan 15, 2025 | 8-K Item 2.02 (results) | $580.11 |
| Oct 17, 2024 | 8-K Item 2.02 (results) | $473.73 |
| Jul 18, 2024 | 8-K Item 2.02 (results) | — |
| Apr 18, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Edwards Lifesciences (EW)Steris (STE)Zimmer Biomet (ZBH)Align Technology (ALGN)Smith & Nephew (SNN)MSA Safety (MSA)Establishment Labs (ESTA)Enovis (ENOV)Cadre (CDRE)Sanara MedTech (SMTI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ISRG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.